Labu ETF News

LABU: A 3X Leveraged ETF Best Avoided

CURE: One Of The Best Performing 3X Shares ETF

Here are 3 stocks to buy on dips from scary geopolitical risks from Russia. These leveraged ETFs move extremely fast so bring your Dramamine.

Direxion's Dave Mazza is seeing many traders using inverse and leveraged ETFs in the recent market movement.

LABU, a triple ETF (3x) from Direxion Funds, tracks the S&P Biotechnology Select Industry Index.

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

MMs “fill” Institutional huge Block-Trades by borrowing otherwise unavailable shares, sell short, hedge the short risk, ultimately cover shorts in accommodative market periods. Short-risk hedge-se

The S&P 500 hit to record close last week, as investors gained optimism from some of President Joe Biden's encouraging announcements regarding booster shots and testing kits.

The S&P 500 hit to record close last week, as investors gained optimism from some of President Joe Biden's encouraging announcements regarding booster shots and testing kits.

Wall Street was downbeat last week with all notable U.S. indexes being in the red. Rising inflation, hawkish Fed and fast-spreading Omicron variant of COVID-19 led to this bloodbath.

Wall Street was downbeat last week with all notable U.S. indexes being in the red. Rising inflation, hawkish Fed and fast-spreading Omicron variant of COVID-19 led to this bloodbath.

The Omicron variant re-asserted the strength of biotech equities, making the Direxion Daily S&P Biotech Bull 3x Shares (LABU) an option for traders. As investors turned up the risk dial, COVID-19 case

United Maritime Capital LLC grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) by 35.3% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 23,000 shares of the companys stock after acquiring an additional 6,000 shares during the period. Direxion Daily S&P Biotech Bull 3x Shares comprises about 1.4% of []

McGuire Investment Group LLC bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 5,540 shares of the companys stock, valued at approximately $306,000. Other large investors have also added to or reduced their stakes in the company. Traynor Capital []

Wall Street was at the record high last week due to upbeat corporate earnings, strong jobs data and Pfizer's pill study.